What's The Effect Of Cistanche Tubulosa, Effects Of The Cistanche Tubulosa Aqueous Extract On The Gut Microbiota Of Mice With Intestinal Disorders

Please contact oscar.xiao@wecistanche.com for more

Disorders of the gut microbiota are associated with many diseases. *e aqueous extract from Cistanche tubulosa (CT), traditional Chinese herbal formula, has been reported to play a role in protecting the human intestine. However, little is known about its effects on the gut microbiota. *e present study was carried out to determine whether the CT aqueous extract can modulate the gut microbiome in mice with intestinal disorders. We found that the damaged intestinal morphology resulting from treatment with cefixime could be rescued using the CT aqueous extract. *e comparison of microbial diversity between mice treated with the CT extract and control mice also indicated that the disorder in the microbiome community of model groups could be restored by treatment with high and medium concentrations of the aqueous extract. Treatment with cefixime led to a significant decrease in lactic acid bacteria; however, the supplementation of the CT aqueous extract recovered the growth of these lactic acid bacteria. Furthermore, the CT aqueous extract was able to moderate the dramatic changes in the metabolic pathways of the gut microbiome induced by cefixime. *ese findings provided an insight into the beneficial effects of the CT aqueous extract on gut microbiota, and they also provided an important reference for the development of related drugs in the future.

Please click here to know more

1. Introduction

Intestinal microorganisms mainly colonize the intestinal lumen and mucosal layer and mutualize with the host through material and energy exchange, transformation, and other processes [1]. *ey are signaling hubs that integrate environmental messages, such as diet, with genetic and immune signals, consequently affecting the host’s metabolism, immunity, nervous system, and response to infections [2]. Normally, there is a dynamic balance between the intestinal flora and hosts; however, gut dysbiosis can result in changes in health/disease balance, immune disorders, and a multitude of diseases [3]. Moderate changes in the gut microbiota are acceptable for the host; however, this can still provide opportunities to amplify the changes in other aggravating factors, such as bacteriophages, bacteriocins, and oxidative stress [4]. Previous studies have shown that the ethanol extract ofCistanche tubulosa (CT), a traditional Chinese herbal formula, can regulate the gut microbial composition in rats [5], and the total glycosides of CT adjusted the disordered gut microbiota [6]. Cistanche species, which mainly parasitize on the roots of Tamarix species, are also called “ginseng of the desert,” and a tonic consisting of the stems of Cistanchedeserticola (CD) and Cistanche tubulosa (CT) is used as an herbal remedy [7]. *e main chemical components of CTphenylethanol glycosides (PHGs), which are antioxidant substances [8, 9], were found to improve reproductive dysfunction [10], suppress hepatic stellate cell activation, block the conduction of signaling pathways in TGF-β1/SMAD [11], and prevent bovine serum albumin-induced hepatic fibrosis in rats [12]. Among more than 100 components in CT, the polysaccharide is also one of the important substances with abundant content [13, 14]. Previous studies have demonstrated that C. deserticola polysaccharides induce melanogenesis in melanocytes, reduce oxidative stress[15], alleviate cognitive dysfunction by regulating antioxidant and anti-inflammatory processes in rats [16], protectPC12 cells against OGD/RP-induced injury [17], enhanceechinacoside absorption in vivo, and affect the gut microbiota [18].Probiotics are live nonpathogenic microorganisms that have health benefits and confer microbial balance in the gastrointestinal tract when administered in adequate amounts [19]. *ey can enhance nonspecific cellular immune responses characterized by the activation of macrophages, natural killer (NK) cells, and antigen-specific cytotoxic T lymphocytes and the release of various cytokines in a strain-specific and dose-dependent manner [20]. Probiotic strains improve the properties of the intestinal epithelium via TJ modulation, and specific probiotic strains have been demonstrated to regulate mucin expression, thereby influencing the properties of the mucus layer and indirectly regulating the gut immune system [21]. Strains of lactic acid bacteria (LAB) and Bifidobacterium are major probiotics that have been used in many fields [22–26]. *eir health benefits are numerous, with their antioxidant capacity being an important factor in their health-related functions[27]. Probiotics can chelate metal ions to prevent them from catalyzing oxidation [28, 29]; they can also increase the expression of antioxidant enzymes [30, 31], produce various metabolites with antioxidant activity [32, 33], mediate antioxidant signaling pathways [34–36], and regulate the enzymes producing reactive oxygen species (ROS) and the response of intestinal microorganisms to oxidative stress[37].A recent study demonstrated that the polysaccharides of CD could stimulate the growth of some lactic acid bacteria, which could benefit human health [38]. However, the content of polysaccharides in CD is different from that in CT [7, 39], and this difference may lead to different effects on intestinal microorganisms. Furthermore, although CD polysaccharides can reduce oxidative stress by activating the NRF2/HO-1 pathway [15], the effects of a single polysaccharide may differ from the overall effect of multiple compositions in CT. *us, it is necessary to precisely define the effects of CT aqueous extracts on intestinal microorganisms. In addition, fans can also resist oxidative stress [40] and suppress lipopolysaccharide-mediated inflammatory responses by activating the theKeap1/Nrf2/HO-1 pathway [41]. *before, determining the effect of the CT aqueous extract is of great value. In addition, the effects of certain constituents of the aqueousCD extract on oxidative stress and intestinal flora suggest that the resistance to oxidative stress might be correlated with intestinal flora changes.In order to fill the gaps in the knowledge on the topics mentioned above, we investigated the effects of the aqueous extract on the gut microbiota of mice with intestinal flora disorders. *These results will provide valuable information about the possible mechanisms through which changes the intestinal flora and confers gut resistance to oxidative stress.https://www.xjcistanche.com/news/what-s-the-effect-of-cistanche-tubulosa-effec-54312367.html

2. Materials and Methods

administered daily at 12:00 h, and other substances were administered daily at 15:00 h. During the experiments, the C, D, E, and F groups were kept in the model state of intestinal disorders. *e feces were collected every seven days on a sterile operable table and stored at −20°C.2.4. Histopathological Observation of the Mice Colon. At the end of the experiment, the mice were killed by cervical dislocation, and their colon contents were collected on a sterile operable table and stored at −80°C; at the same time, colonic tissue samples were fixed in 10% neutral formalin.*en, the samples were dehydrated using gradient concentration of ethanol, hyalinized using xylene, embedded in paraffin, sectioned, and stained with hematoxylin-eosin. Morphological changes in the colonic mucosa were observed and compared using an optical microscope. Villus length and crypt depth in the colon was measured, and the ratio of villus length to crypt depth (V/C value) was calculated (51).2.5. DNA Extraction and Library Construction. DNA was extracted from the feces using the E.Z.N.A. ®Soil DNA Kit(Omega Bio-Tek, Norcross, GA, USA) according to the manufacturer's protocol. DNA quality was determined using a fluorometer (QuantiFluor™–ST, Promega Corporation, USA). Paired primers in the V3-V4 region of 16s rDNA were designed to amplify the region and produce 466 bp DNA fragments. *e forward primer was 341F (-5-CCTACGGGNGGCWGCAG-3-), and the reverse primerwas 806R (-5-GGACTACHVGGGTATCTAAT-3-). EachPCR volume was 25 μL, containing 2.5 μL of 10 × PCR buffer,2 μL of dNTPs, 1 μL of each primer, and 20–30 ng of template DNA. *en, the indexed adapters were attached to the end of the amplicons to generate sequencing libraries. *libraries were validated using a QuantiFluor™ fluorometer and quantified to 10 nmol.2.6. 16s rRNA Gene Sequencing and Microbial CommunityAnalysis. *e Illumina platform (Illumina MiSeq) was used to obtain 2 × 250 bp paired-end data. Operational taxonomic units (OTUs) were obtained using Uparse software through standard clustering with 97% similarity. *e naive Bayesianassignment algorithm of the RDP classifier was used to align the OTUs with the Greengene database Release 13.5 and perform species annotation. *e alpha diversity of gut microbiota was calculated using the Shannon and Simpson indices, and the differences between groups were analyzed by linear discriminant analysis Effect Size (LEfSe). *e beta diversity was analyzed by principal coordinate analysis (PCoA) of Brady–Curtis dissimilarities. PICRUSt2 was used to estimate the microbial metabolic capacity of the gut microbiome [42].2.7. Statistical Data Analysis. SPSS 20 was used for one-way ANOVA, and the experimental data were expressed as X ± S; X indicates the average value, and S indicates the standard deviation.

3. Results

3.1. 8e Effffect of the CT Aqueous Extract on Colon Morphology.*e representative compounds (echinacoside and acetonide)and their concentrations of the CT extract were validated by HPLC (Figure S1). To determine the effect of the aqueous extract on the gut, we investigated the length of colon villi and depth of recesses following the treatment with the aqueous extract. *e colon villi in the normal and high-dose groups (A, B, and D) were longer and fingerlike, whereas the colon villi in the model and low-dose groups (C and F) were short, and the tips of the colon villi were broken (Figure 1). Accordingly, high-dose CT aqueous extract significantly increased the length of colon villi and reduced recess depth in mice with intestinal disorders compared with the mice in the model group (P < 0.01). In contrast, recess depth was not significantly different between the high-dose group and the normal group (P > 0.05) (Table S1). *These results indicated that the high dose of the CT aqueous extract can improve the morphology inside the colon of mice with intestinal disorders.3.2. 8e Effffect of the CT Aqueous Extract on the Diversity ofGut Microbiota. We performed 16s rRNA gene sequencing to investigate the potential cause of the morphological changes inside the colon and investigate the changes in gut microbiota following treatment with the CT aqueous extract. An average of 100,553 effective tags, ranging from 77,734 to125,144, was obtained from the raw data (Table S2). *stags were clustered into 4932 OTUs (Table S3). We then analyzed the diversity of the gut microbiota based on Theseus. *e Shannon and Simpson indexes showed no difference between the A group (normal with the CT aqueous extract) and the B group (normal without the CT aqueous extract) (Figure 2(a)). *is indicated that in the mice without the cefixime treatment, the CT aqueous extract might have had no additional beneficial or harmful effects on the theα-diversity of the gut microbiota. However, the α-diversity in the model group (C) showed a decreasing trend compared to that in the normal groups. *e mice treated with highand middle-dose CT aqueous extracts showed signs ofα-diversity recovery, whereas such a phenomenon was not observed in mice treated with the low-dose CT aqueous extract (Figure 2(a)). Meanwhile, the PCoA revealed that the normal groups (A and B) and intestinal disorder groups administered high-dose (D) and middle-dose (E) CTaqueous extracts tended to have shorter intersample distances than those in the model group and in the low-dose CTaqueous extract supplement group (F) (Figure 2(b)). *results indicated that the CT aqueous extract could help improve the diversity of the gut microbiota in mice with intestinal disorders.3.3. Changes in the Composition of Gut Microbiota Treatedwith the CT Aqueous Extract. *e microbiota composition profiles were compared among different groups. At the phylum level, the relative abundance of Proteobacteria in the model group was higher than that in the other groups.https://www.xjcistanche.com/news/protective-effects-of-taxifolin-on-pazopanib-i-54206149.html

(Figure 3(a)). *e increase in Proteobacteria suggested that the microbiome of model mice was changed by cefixime and that the CT aqueous extract might benefit the intestinal microbiota as the increased prevalence of Proteobacteria is a hub marker of disordered intestinal flora [43–45]. In addition, at the genus level, the relative abundance of Lactobacillus in the model group decreased compared with that in the normal and high-dose groups; however, it increased compared with that in the middle- and low-dose group(Figure 3(b)). *These results indicated that the high-dose CTaqueous extract might promote the growth of some bacteria from the genus Lactobacillus. Differential microbiota between the studied groups was further determined according to the LEfSe analysis. *analysis showed that, after the treatment with cefixime, the relative abundances of Turicibacter, Alphaproteobacteria, Acidobacteria, Betaproteobacteriales, and Chloroflflexi signifificantly increased, whereas the relative abundances of lactobacillus, Eubacterium_nodatum_group, Pseudonocardiales, and Christensenellaceae_R-7_group significantly decreased compared with those in the normal group(Figure 4(a)). Strikingly, when the model group was supplemented with the high-dose CT aqueous extract, the relative abundances of Muribaculaceae, Lactobacillus, Kineosporiaceae, Eubacterium no datum group, and Pedobacterwere significantly increased compared to those in the model group. Meanwhile, the relative abundances of Rhodobacter, Ruminococcaceae UCG_013, Roseburia, Ruminiclostridium_9, and Candidatus Stoquefifichus decreased signifies-cantly compared to those in the model group (Figure 4(b)).

3.4. Functions of the Gut Microbiota Related to the Treatment with the CT Aqueous Extract. We used PICRUSt2 software to predict the metabolic pathways of the gut microbiota, and the normal group was used as a reference to analyze the changes in other groups. Under the cefixime treatment, the relative abundance of ethylbenzene degradation, biosynthesis of siderophore group nonribosomal peptides, and metabolism of xenobiotics by cytochrome P450 pathways increased; after the treatment with high- and middle-doses aqueous extracts, their relative abundance returned to normal levels. Meanwhile, the relative abundance of thecyanoamino acid metabolism pathway decreased under thecefifixime treatment; however, it increased after the treatment with the high-dose CT aqueous extract. Furthermore, in general, the changes in different metabolite pathways after the treatment with cefixime were significant compared with those in the normal group; however, the addition of the aqueous extract was able to prevent excessive changes(Figure 5).

4. Discussion

groups are predominant in the human gut; the ratio ofBacteroidetes/Firmicutes was found to be decreased in obese people compared with that in lean people, and this ratio was found to increase with weight loss in people on two types of low-calorie diet [38, 41, 43–45, 48, 53, 54]. Meanwhile, Turicibacter, which is associated with obesity [55], was significantly elevated in the model group compared to that in the other groups. Notably, the diversity of gut microbiota in the model mice was improved by the addition of the aqueous extract. We noted some specific intestinal bacteria in mice under different treatments; for example, Lactobacillus and Muribaculaceae were the two main bacterial genera that increased in the group treated with the high-dose aqueous extract compared to those in the model group(Figure 4). Recent studies have indicated that the polysaccharides of CT aqueous extracts possess significant antioxidant activities in vitro [56] and can promote the growth of some lactic acid bacteria, which could benefit host health [43]. In parallel, Muribaculaceae are probiotic organisms linked to longevity [57]. *ese suggested that the mechanism by which the CT aqueous extract improves the gut microbiota may be the promotion or protection of the growth of probiotic organisms. Another bacterium worthy of note was the bacterium YE57. Although the high-dose CTaqueous extract promoted the relative abundance of bacterium YE57 in the present study (Figure 4), previous studies have found that its abundance was higher in the normal gut than that in the gut treated with high-concentration herbal tea residue [58] and that its abundance was reduced after the intervention with Bacillus licheniformis combined with XOS(xylooligosaccharides) [59]. *us, the role of this bacterium in the gut microbiota deserves further study. Besides, the relatively small sample number in this study might cause a measure of false positive and false negative, and future study on larger samples is suggested to validate the identified bacterial markers.

CT aqueous extract composition might be important for its effects on the composition and functional changes in the gut microbiota of mice with intestinal disorders.PSGs are common active components found in CD andCT, and echinacoside was identified as the major PNG in [60]. In the past decades, echinacoside has been shown to possess many pharmacological activities, such as antiaging and neuroprotective effects, improvement of cardiac function, reduction of hyperlipidemia and hyperglycemia, and prevention of obesity-induced diabetes and metabolic syndrome [53, 61–65]. In fact, we detected changes in the metabolic pathways of the gut microbiota.*e treatment of cefixime led to the enrichment of bacteria related to ethylbenzene degradation and biosynthesis of siderophore group nonribosomal peptides, while the treatments with the high- and middle-dose CT aqueous extract could alleviate these changes, indicating that this extract moderated the bacterial community-related to these functions. In addition, the increased bacterial enrichment related to the cyanoamino acid metabolism pathway under the treatment with the high-dose aqueous extract and its decreased enrichment in model mice indicated that the CT aqueous extract can promote the metabolism of cyanoamino acid. *e changes in relevant metabolites might provide this aqueous extract with pharmacological activities.

Although the mechanism by which the CT aqueous extract changes the composition and function of intestinal microbiota is complex, there are some clues to speculate about the potential mechanism. It has been reported that both lactic acid bacteria and CT aqueous extracts can antagonize oxidative stress. Oxidative stress occurring during inflammation is a common factor that exacerbates intestinal disorders by strongly reducing gut microbial diversity and promoting the surge of specific bacteria (4).On the contrary, reactive oxygen species also promote the selective growth of bacterial groups through nitrate and tetrathionate respiration [66–68]; for example, bacteria from the family Enterobacteriaceae can grow rapidly as a consequence of changes in the composition of the intestinal flora under oxidative conditions during inflammation [69, 70]. Most living organisms evolve enzymatic defenses, nonenzymatic antioxidant defenses, and repair mechanisms to scavenge oxygen radicals [71].

However, these native antioxidant systems are generally not sufficient to prevent oxidative damage in living organisms. Several additional synthetic antioxidants, including butylated hydroxyanisole and butylated hydroxytoluene, have been widely used to decrease oxidation, but their safety has been questioned [72, 73]. *before, researchers have turned to find safer and more natural antioxidants obtained from naturally occurring substances. Due to the ability of both polysaccharides and lactic acid bacteria to eliminate oxidative stress, determining the precise antioxidative mechanism of CT aqueous extracts on the intestinal microbiota requires further investigation in the future.

In conclusion, we found that the CT aqueous extract was able to improve intestinal gut microbiota in mice with intestinal disorders by promoting diversity, moderating the metabolic changes, and remodeling the structure of gut microbiota, and these results may provide a reference for the development of related drugs in the future. Data Availability*e statistics of the operational taxonomic units among each sample data used to support the findings of this study are included within the supplementary information files, and the 16s rRNA sequencing data used to support the findings of this study will be released upon publication. Conflicts of Interest*e authors declare that they have no conflicts of interest.Acknowledgments*is study was financially supported by grants from theNational Natural Science Foundation of China (81860766). Supplementary MaterialsFigure S1: HPLC detection of the Cistanche tubulosaaqueous extract. (a) *e peak of echinacoside and acteosidein the reference material appears at 5.066 min and 9.988 min separately. (b) *e peak of echinacoside and acetonide in the aqueous extract appears at 5.097 min and 10.076 min separately, and the concentrations are 236 mg/g and 12.7 mg/separately. Table S1: the length of colon villi and depth of recesses. Table S2: Statistical information of the 16S rRNA sequencing data. Table S3: statistic of the operational taxonomic units among each sample. (supplementary material)

The article comes from Hindawi Evidence-Based Complementary and Alternative Medicine Volume 2021, Article ID 4936970, 11 pages https://doi.org/10.1155/2021/4936970